News and Analysis

French biotech firm ImCheck gathers $53 mln Series B

ImCheck Therapeutics, a French biotech company, has raised $53 million in Series B financing.

-

ImCheck Therapeutics, a French biotech company, has raised $53 million in Series B financing. Pfizer Ventures and Bpifrance led the round.

Source: Press Release